Get the Stockscreener App
89.02
7.97%
6.57
Irhythm Technologies Inc stock is traded at $89.02, with a volume of 552.74K.
It is up +7.97% in the last 24 hours and up +17.63% over the past month.
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
See More
Previous Close:
$82.45
Open:
$83.13
24h Volume:
552.74K
Relative Volume:
0.96
Market Cap:
$2.67B
Revenue:
$560.03M
Net Income/Loss:
$-150.66M
P/E Ratio:
-25.73
EPS:
-3.46
Net Cash Flow:
$-87.43M
1W Performance:
+20.72%
1M Performance:
+17.63%
6M Performance:
+0.09%
1Y Performance:
+0.83%
1-Day Range:
$82.55
$89.10
1-Week Range:
$71.00
$89.10
52-Week Range:
$55.92
$124.11
Irhythm Technologies Inc Stock (IRTC) Company Profile
Name
Irhythm Technologies Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
89.02 | 2.67B | 560.03M | -150.66M | -87.43M | -3.46 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Technologies Inc Stock (IRTC) Latest News
20,173 Shares in iRhythm Technologies, Inc. (NASDAQ:IRTC) Bought by Dynamic Technology Lab Private Ltd - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Westfield Capital Management Co. LP - MarketBeat
Eagle Asset Management Inc. Buys 31,193 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Champlain Investment Partners LLC Lowers Stock Position in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Long Term Trading Analysis for (IRTC) - Stock Traders Daily
B. Metzler seel. Sohn & Co. Holding AG Takes Position in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $52.50 Million Stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
IRhythm Technologies To Participate In The Citi 2024 Global Healthcare Conference - Barchart
iRhythm Technologies to Present at Citi 2024 Global Healthcare Conference | IRTC Stock News - StockTitan
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference - The Manila Times
IRTCiRhythm Technologies, Inc Latest Stock News & Market Updates - StockTitan
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring - The Manila Times
iRhythm's New Studies Show 94.8% Device Compliance, 14% Better Comfort with Zio Monitor | IRTC Stock News - StockTitan
Short Interest in iRhythm Technologies, Inc. (NASDAQ:IRTC) Expands By 8.7% - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Bought by State of New Jersey Common Pension Fund D - MarketBeat
iRhythm Technologies amends equity plan and code of ethics - Investing.com
iRhythm Technologies Updates Equity Incentive Plan - TipRanks
IRhythm Technologies : Amendments to Code of Ethics Form 8 K - Marketscreener.com
Frank Sands' Strategic Acquisition in iRhythm Technologies Inc - GuruFocus.com
(IRTC) Trading Report - Stock Traders Daily
Capital Research Global Investors Reduces Stake in iRhythm Techn - GuruFocus.com
Artisan Partners Limited Partnership Bolsters Stake in iRhythm T - GuruFocus.com
Abstract 4139306: Digital engagement with a patient smartphone app and text messaging is associated with increased compliance in patients undergoing long-term continuous ambulatory cardiac monitoring - AHA Journals
Abstract 4143857: Characterization of Arrhythmia Occurrence During Sleep and Activity in Patients Undergoing Long-Term Continuous Ambulatory ECG Monitoring - AHA Journals
Fiera Capital Corp Sells 11,553 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Have Insiders Sold iRhythm Technologies Shares Recently? - Simply Wall St
New York State Common Retirement Fund Trims Stock Position in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm technologies director buys $500,866 in common stock By Investing.com - Investing.com Canada
iRhythm technologies director buys $500,866 in common stock - Investing.com
IRhythm Technologies To Participate In The Wolfe Research 2024 Healthcare Conference - Barchart
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference - WICZ
IRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference - Marketscreener.com
Director Abhijit Talwalkar Acquires 6,664 Shares of iRhythm Tech - GuruFocus.com
Quentin S. Blackford Sells 16,145 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) Stock - MarketBeat
Insider Buying: iRhythm Technologies, Inc. (NASDAQ:IRTC) Director Buys 6,664 Shares of Stock - MarketBeat
iRhythm technologies CEO Blackford sells $1.25 million in stock By Investing.com - Investing.com UK
iRhythm technologies CEO Blackford sells $1.25 million in stock - Investing.com
iRhythm Technologies (NASDAQ:IRTC) Trading Up 7.8%What's Next? - MarketBeat
iRhythm Technologies Inc (IRTC) Trading 4.41% Higher on Nov 4 - GuruFocus.com
Harbor Capital Advisors Inc. Has $5.94 Million Stock Holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Emerging Opportunities in the Ecg Sensor Patch Market - openPR
Q1 EPS Forecast for iRhythm Technologies Lifted by Analyst - MarketBeat
Trend Tracker for (IRTC) - Stock Traders Daily
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Earnings call: iRhythm Reports Growth Amid FDA Remediation Efforts By Investing.com - Investing.com Australia
iRhythm Leaders Concealed Heart Monitor Deficiencies, Suit Says - Bloomberg Law
FDA clears iRhythm’s second 510(k) in response to warning letter - MedTech Dive
iRhythm Technologies Third Quarter 2024 Earnings: EPS Misses Expectations - Simply Wall St
Here’s Why iRhythm Technologies (IRTC) Slid in Q3 - Insider Monkey
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported, And Analysts Assigned A US$101 Price Target - Yahoo Canada Finance
Irhythm Technologies Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):